Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data

Results from a Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate, or High Risk, Relapsed/Refractory Myelofibrosis

(2020) Naveen Pemmaraju et al.   BLOOD

New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm

(2020) Xiang Zhang et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm

(2020) Wei Wang et al.   HAEMATOLOGICA

Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm

(2020) Mohamed A. Kharfan-Dabaja et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Blastic Plasmacytoid Dendritic Cell Neoplasm

(2020) Eric Deconinck   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation

(2019) Fatima Hamadeh et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia

(2019) Nolwenn Lucas et al.   LEUKEMIA

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

(2019) Naveen Pemmaraju et al.   NEW ENGLAND JOURNAL OF MEDICINE

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects

(2019) Maria Rosaria Sapienza et al.   Cancers

Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm

(2019) Narittee Sukswai et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Multicenter Analysis of Outcomes in Blastic Plasmacytoid Dendritic Cell Neoplasm Offers a Pre-Targeted Therapy Benchmark

(2019) Justin Taylor et al.   BLOOD

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

(2019) Emily Y. Jen et al.   CLINICAL CANCER RESEARCH

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies

(2019) Testa et al.   Cancers

Results from Phase 1/2 Trial of Tagraxofusp in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

(2019) Paul G. Richardson et al.   BLOOD

DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance

(2019) Katsuhiro Togami et al.   JOURNAL OF CLINICAL INVESTIGATION

Allogeneic Hematopoietic Cell Transplantation Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm in First Complete Remission: Systematic Review and Meta-analysis

(2018) Mohamed A. Kharfan-Dabaja et al.   Clinical Lymphoma Myeloma & Leukemia

A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells

(2017) A Ray et al.   LEUKEMIA

Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond

(2017) Naveen Pemmaraju   Current Hematologic Malignancy Reports

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches

(2016) Livio Pagano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile

(2015) Lourdes Martín-Martín et al.   Oncotarget

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

(2014) A. E. Frankel et al.   BLOOD

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent

(2014) F. Angelot-Delettre et al.   HAEMATOLOGICA

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia

(2009) Francine Garnache-Ottou et al.   BRITISH JOURNAL OF HAEMATOLOGY